Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.67 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.67 |
| ▸ | APAF1 | O14727 | 1/20 | 0.67 |
| ▸ | NPC1 | O15118 | 1/20 | 0.67 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 1/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.67 |
| ▸ | HTT | P42858 | 1/20 | 0.67 |
| ▸ | RAB9A | P51151 | 1/20 | 0.67 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.67 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.67 |
| ▸ | FDPS | P14324 | 17/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5285827 | 0.95 | MEN1 (0.65) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL294165 | 0.95 | MEN1 (0.65) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Sulfuric Acid SCHEMBL31650675 | 0.93 | MEN1 (0.78) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Sulfuric Acid SCHEMBL582395 | 0.93 | MEN1 (0.63) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Sulfuric Acid SCHEMBL31650730 | 0.93 | MEN1 (0.78) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Sulfuric Acid SCHEMBL27783819 | 0.92 | MEN1 (0.61) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Sulfuric Acid SCHEMBL21195046 | 0.92 | MEN1 (0.76) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL2357881 | 0.91 | MEN1 (0.59) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL305739 | 0.91 | MEN1 (0.59) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL7742082 | 0.91 | MEN1 (0.59) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114883536-A | Preparation method of hollow fiber tubular lithium battery anode | 上海大学 | 2022-08-09 | — | — | CN | claimed |
| CN-107710462-B | Electrochemical hydrogen storage electrode and battery | 巴斯夫公司 | 2022-08-02 | — | — | CN | claimed |
| CN-110713501-B | Preparation method of glucosamine calcium sulfate salt | 山东润德生物科技有限公司 | 2021-04-06 | — | — | CN | claimed |
| EP-1812382-B1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF SE (DE) | 2013-01-23 | — | — | EP | claimed |
| US-20090112017-A1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF AKTIENGESSELLSCHAFT (DE) | 2009-04-30 | — | — | US | claimed |
| WO-2008022983-A2 | CONDUCTIVE POLYMER GELS | BASF SE (DE) | 2008-02-28 | — | — | WO | claimed |
| EP-1812382-A1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-01 | — | — | EP | claimed |
| EP-1663921-B1 | METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS | BASF AG (DE) | 2007-05-02 | — | — | EP | claimed |
| US-20070055084-A1 | Method for producing haloalkanes from alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2007-03-08 | — | — | US | claimed |
| EP-1663921-A2 | METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS | BASF AKTIENGESELLSCHAFT (DE) | 2006-06-07 | — | — | EP | claimed |
| WO-2006048171-A1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF AKTIENGESELLSCHAFT (DE) | 2006-05-11 | — | — | WO | claimed |
| WO-2005026089-A2 | METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS | BASF AKTIENGESELLSCHAFT (DE) | 2005-03-24 | — | — | WO | claimed |
| WO-2025132521-A1 | ELECTROCHEMICAL SYSTEM COMPRISING A GALLIUM REDOX MEDIATOR AND USES THEREOF | FUNDACIÓN CENTRO DE INVESTIGACIÓN COOPERATIVA DE ENERGÍAS ALTERNATIVAS CIC ENERGIGUNE FUNDAZIOA (ES) | 2025-06-26 | — | — | WO | disclosed |
| CN-119039071-A | Method and apparatus for preparing water-soluble compound fertilizer | 中化化肥有限公司临沂农业研发中心 | 2024-11-29 | — | — | CN | disclosed |
| CN-117440991-A | Polysiloxane composition | 默克专利有限公司 | 2024-01-23 | — | — | CN | disclosed |
| CN-112771019-B | Catalyst system for oxidizing para-xylene and/or meta-xylene to the corresponding carboxylic acid | 沙特基础工业全球技术有限公司 | 2023-07-07 | — | — | CN | disclosed |
| EP-1663921-A2 | METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS | BASF AKTIENGESELLSCHAFT (DE) | 2006-06-07 | — | — | EP | disclosed |
| WO-2006048171-A1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF AKTIENGESELLSCHAFT (DE) | 2006-05-11 | — | — | WO | disclosed |
| WO-2005085207-A2 | METHOD FOR THE PRODUCTION OF IONIC FLUIDS THE CATION OF WHICH COMPRISES A QUATERNARY SP2 - HYBRIDISED NITROGEN ATOM | BASF AKTIENGESELLSCHAFT (DE) | 2005-09-15 | — | — | WO | disclosed |
| WO-2005026089-A2 | METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS | BASF AKTIENGESELLSCHAFT (DE) | 2005-03-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090112017-A1 | METHOD FOR PRODUCING POLYISOCYANATES | PGLS, INMT, PNMT | MEN1 866/4885HSP90AA1 4668/4885KMT2A 1556/4885 |
| US-20070055084-A1 | Method for producing haloalkanes from alcohols | ADH1C, HDHD5, ADH5 | MEN1 4351/4885HSP90AA1 364/4885KMT2A 735/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.